How worried should drug companies be about supplements eating into their monopoly profits?
A lot—as this story will show. Please share it with anyone you know who is suffering from Alzheimer’s or is worried about it. Of course, just about everyone worries about Alzheimer’s. It currently afflicts 5.2 million people in the US and is the seventh leading cause of death. The cost of treating it is estimated at $148 billion. Mary Newport, MD, has been medical director of the neonatal intensive care unit at Spring Hill Regional Hospital in Florida since it opened in 2003. About the same time the unit opened, her husband Steve, then 53, began showing signs of progressive dementia, later diagnosed as Alzheimer’s Disease. “Many days, often for several days in a row, he was in a fog; couldn’t find a spoon or remember how to get water out of the refrigerator,” she said. They started him on Alzheimer’s drugs—Aricept, Namenda, Exelon—but his disease worsened steadily. (It should be noted that the latest research shows that the various Alzheimer’s drugs, like Aricept, have proven disappoin
Related Questions
- Many energy companies are large corporations that have made huge profits, even during times of high energy prices. What impact will this package have on such companies?
- What is the specific advantage of eating Resveratrol supplements over drinking red wines?
- Do veterinarians get kickbacks from drug companies?
